glp-1 drug companies 3 Stock Picks: LLY, VKTX, and GPCR GLP-1 Drugs
Description
doi: 10.1210/clinem/dgab722 38 WillardFSDourosJDGabeMBShowalterADWainscottDBSuterTMet al
This principle of gradual adjustment also applies when discontinuing the medication
doi: 10.1016/S0140-6736(87)91194-9
124 GLP-1, by activating its receptor, increases insulin secretion and reduces glucagon secretion, thereby lowering blood sugar levels
Acta Endocrinol (Buchar)
